DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DexTech Medical AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11173
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology platform includes GuaDex, which uses dextran to develop new product candidates including OsteoDex, for the treatment of skeletal metastasis in castration-resistant prostate cancer. DexTech offers SomaDex for the treatment of acromegalia, neuroendocrine tumours and palliative treatment of CRPC; and CatDex, a preclinical product candidate for instillation therapy of superficial bladder cancer. The company’s technology platform provides candidate medications in oncology and anti bacterial agent. It licences its technology to other large drug companies for various applications. DexTech is headquartered in Uppsala, Sweden.

DexTech Medical AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DexTech Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DexTech Medical AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
DexTech Medical Enters into Research Agreement with Roche 10
Exini Diagnostics Enters into Agreement with DexTech Medical for OsteoDex 11
Equity Offering 12
DexTech Medical Raises USD4.5 Million in Private Placement of Shares 12
DexTech Medical AB – Key Competitors 13
DexTech Medical AB – Key Employees 14
DexTech Medical AB – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
DexTech Medical AB, Pharmaceuticals & Healthcare, Key Facts 2
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DexTech Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DexTech Medical AB, Deals By Therapy Area, 2012 to YTD 2018 8
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DexTech Medical Enters into Research Agreement with Roche 10
Exini Diagnostics Enters into Agreement with DexTech Medical for OsteoDex 11
DexTech Medical Raises USD4.5 Million in Private Placement of Shares 12
DexTech Medical AB, Key Competitors 13
DexTech Medical AB, Key Employees 14

List of Figures
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DexTech Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orkuveita Reykjavikur:企業の戦略的SWOT分析
    Orkuveita Reykjavikur - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Credit Agricole CIB SA:企業の戦略的SWOT分析
    Credit Agricole CIB SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cermaq Group AS:企業の戦略的SWOT分析
    Cermaq Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Iridium Communications Inc (IRDM):企業の財務・戦略的SWOT分析
    Iridium Communications Inc (IRDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Galp Energia SGPS SA (GALP):電力:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Qiagen NV (QIA)-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen NV (Qiagen) is a provider of molecular testing solutions. Its solutions include sample and assay technologies, bioinformatics and automation systems. Qiagen’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue. The company’s produc …
  • Gjensidige Forsikring ASA :企業のM&A・事業提携・投資動向
    Gjensidige Forsikring ASA  - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gjensidige Forsikring ASA  Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Singapore Airlines Ltd:企業のM&A・事業提携・投資動向
    Singapore Airlines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Singapore Airlines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Swisscom, Ltd.:企業のM&A・事業提携・投資動向
    Swisscom, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swisscom, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • South Jersey Industries Inc (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • The Weir Group Plc (WEIR):電力:M&Aディール及び事業提携情報
    Summary The Weir Group Plc (Weir Group) is a provider of engineering solutions. The company designs and manufactures highly engineered products and services for minerals, oil and gas, and power industries. Its products and service portfolio include pressure pumping equipment, pressure control produc …
  • Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research …
  • Cathay Pacific Airways Limited
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kangwon Land Inc.
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Cheesecake Factory Incorporated:戦略・SWOT・企業財務分析
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Bangladesh Power Development Board:電力:M&Aディール及び事業提携情報
    Summary Bangladesh Power Development Board (BPDB) is an integrated electric utility. It generates using gas, furnace, diesel, hydro, coal and solar; and imports power from India. The company operates independent power plants /SIPP, rental power plant and REB using steam turbine, gas turbine, combine …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • A & J Mucklow Group plc (MKLW):企業の財務・戦略的SWOT分析
    Summary A & J Mucklow Group Plc (A&J Mucklow) is a real estate service provider that offers investment and development of industrial and commercial properties. The company provides real estate development, property management, property development, project management, and real estate investment serv …
  • Scienion AG:製品パイプライン分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆